Funding for this research was provided by:
National Institute of Mental Health (R01MH107275)
Center for AIDS Research, Johns Hopkins University (P30AI094189)
National Institute for Allergy and Infectious Diseases Division of Intramural Research, National Institutes of Health (Not applicable. There is no specific award number or document for this U.S. government agency.)
Received: 8 February 2017
Accepted: 7 October 2017
First Online: 23 October 2017
Ethics approval and consent to participate
: The study has been approved by the Research and Ethics Committee of the Uganda Virus Research Institute (GC/127/16/06/505), the Ugandan Council of Science and Technology (SS 3868), the Western Institutional Review Board (20031318), and the Johns Hopkins School of Medicine Institutional Review Board (IRB00062089). All participants provided oral and written consent and assent as appropriate.
: Not applicable.
: emocha Mobile Health Inc. is the company that developed and supported the smartphone application used in this protocol. LC and RB are entitled to royalties on certain non-research revenue generated by this company and own company equity. Specific to this study, LC and RB have and will receive no royalties or compensation from emocha Mobile Health Inc. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. LC and RB will not be members of the DMC established for this study. All other study team members have no known competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.